The Substantia Nigra Pars Reticulata Modulates Error-Based Saccadic Learning in Monkeys.


Journal

eNeuro
ISSN: 2373-2822
Titre abrégé: eNeuro
Pays: United States
ID NLM: 101647362

Informations de publication

Date de publication:
Historique:
received: 30 11 2020
revised: 24 02 2021
accepted: 01 03 2021
pubmed: 13 3 2021
medline: 22 6 2021
entrez: 12 3 2021
Statut: epublish

Résumé

The basal ganglia have long been considered crucial for associative learning, but whether they also are involved in another type of learning, error-based motor learning, is not clear. Error-based learning has been considered the province of the cerebellum. However, learning to use a robotic arm and saccade adaptation, which use error-based learning, are facilitated by motivation, which is a function of the basal ganglia. Additionally, patients with Parkinson's disease, a basal ganglia deficit, show slower saccade adaptation than age matched controls. To further investigate whether the basal ganglia actually influence error-based learning, we reversibly inactivated the oculomotor portion of the substantia nigra pars reticulata (SNr) in two monkeys and tested saccade adaptation. Here, we show that nigral inactivation affected saccade adaptation. In particular, the inactivation facilitated the amplitude decrease adaptation of ipsiversive saccades. Consistent with previous studies, no effect was seen on the amplitude of the ipsiversive saccades when we did not induce adaptation. Therefore, the facilitated adaptation was not caused by inactivation directly modulating ipsiversive saccades. On the other hand, the kinematics of corrective saccades, which represent error processing, were changed after the inactivation. Thus, our data suggest that the oculomotor SNr assists saccade adaptation by strengthening the error signal. This effect indicates the basal ganglia influence error-based motor learning, a previously unrecognized function.

Identifiants

pubmed: 33707204
pii: ENEURO.0519-20.2021
doi: 10.1523/ENEURO.0519-20.2021
pmc: PMC8114898
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : P51 OD010425
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY014263
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY023277
Pays : United States

Informations de copyright

Copyright © 2021 Kojima and May.

Références

Brain Res. 1980 May 19;190(1):39-50
pubmed: 6769538
J Neurosci. 2010 Mar 10;30(10):3715-27
pubmed: 20220005
Exp Brain Res. 1999 Apr;125(4):397-409
pubmed: 10323285
Brain Res. 2010 Dec 17;1366:93-100
pubmed: 20951682
Nat Rev Neurosci. 2018 Jun;19(6):338-350
pubmed: 29643480
J Neurosci. 2006 Jul 19;26(29):7741-55
pubmed: 16855102
Physiol Rev. 2000 Jul;80(3):953-78
pubmed: 10893428
Brain Res. 1977 Oct 21;135(1):147-52
pubmed: 410480
J Neurosci. 2009 Apr 22;29(16):5266-75
pubmed: 19386923
J Neurophysiol. 2002 Jun;87(6):2778-89
pubmed: 12037180
Neuroscience. 1987 May;21(2):529-39
pubmed: 3039404
Neuroscience. 2017 Jul 4;355:113-125
pubmed: 28499971
Vis Neurosci. 1998 Sep-Oct;15(5):903-22
pubmed: 9764533
Prog Brain Res. 2008;171:153-9
pubmed: 18718294
J Neurophysiol. 2007 Jun;97(6):4129-42
pubmed: 17392414
J Neurophysiol. 2010 Dec;104(6):3146-67
pubmed: 20926614
J Neurophysiol. 2007 Jun;97(6):4096-107
pubmed: 17442764
J Neurophysiol. 1997 Feb;77(2):874-95
pubmed: 9065856
Prog Brain Res. 2005;148:95-109
pubmed: 15661184
J Neurophysiol. 1983 May;49(5):1285-301
pubmed: 6306173
Vision Res. 1972 Nov;12(11):1795-808
pubmed: 4627952
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8987-E8995
pubmed: 30185563
J Neurophysiol. 1983 May;49(5):1230-53
pubmed: 6864248
Brain Res Bull. 1997;43(5):473-83
pubmed: 9250621
J Neurophysiol. 2015 Jul;114(1):125-37
pubmed: 25855693
J Neurosci. 2012 Nov 21;32(47):16917-32
pubmed: 23175843
Brain. 2002 Jul;125(Pt 7):1570-82
pubmed: 12077006
J Comp Neurol. 1985 Apr 1;234(1):105-16
pubmed: 3980783
Exp Brain Res. 2010 Jul;204(2):145-62
pubmed: 20544185
J Comp Neurol. 1987 Nov 8;265(2):224-41
pubmed: 3320110
Curr Opin Neurobiol. 2000 Dec;10(6):732-9
pubmed: 11240282
J Neurophysiol. 2002 Feb;87(2):679-95
pubmed: 11826037
J Neurophysiol. 1985 Jan;53(1):292-308
pubmed: 2983038
J Appl Physiol. 1966 May;21(3):1068-70
pubmed: 4958032
Prog Brain Res. 2019;249:169-181
pubmed: 31325976
J Comp Neurol. 1977 Jun 1;173(3):583-612
pubmed: 404340
J Fr Ophtalmol. 2012 Apr;35(4):242-50
pubmed: 22018708
J Physiol. 1969 Jun;202(2):437-70
pubmed: 5784296
J Neurophysiol. 2008 Oct;100(4):1949-66
pubmed: 18650308
J Neurosci. 2009 Dec 2;29(48):15213-22
pubmed: 19955374
J Neurophysiol. 2019 Jun 1;121(6):2153-2162
pubmed: 30995136
J Neurophysiol. 2015 Jan 15;113(2):633-46
pubmed: 25355957
J Neurosci. 1981 Feb;1(2):121-5
pubmed: 6167690
Exp Brain Res. 2007 Feb;177(2):209-22
pubmed: 16951960
Vision Res. 1980;20(6):535-8
pubmed: 6776685
J Neurophysiol. 1995 Jun;73(6):2313-33
pubmed: 7666141
Vision Res. 2000;40(20):2763-77
pubmed: 10960650
Ann N Y Acad Sci. 2003 Jun;991:199-213
pubmed: 12846988
Sci Rep. 2017 Aug 29;7(1):9566
pubmed: 28852092
Mov Disord. 2017 Nov;32(11):1537-1545
pubmed: 28843013
Exp Brain Res. 2002 Feb;142(4):439-62
pubmed: 11845241
Trends Neurosci. 1989 Mar;12(3):94-101
pubmed: 2469224
J Neurophysiol. 1998 Mar;79(3):1193-209
pubmed: 9497401
J Neurosci. 2008 Oct 22;28(43):11071-8
pubmed: 18945914
J Neurosci. 2010 Oct 20;30(42):14235-44
pubmed: 20962244
Neuron. 2011 Nov 3;72(3):469-76
pubmed: 22078506
J Neurophysiol. 2003 Aug;90(2):1235-44
pubmed: 12711711
J Neurophysiol. 2008 Aug;100(2):1098-112
pubmed: 18579662
Prog Neurobiol. 2004 Jan;72(1):27-53
pubmed: 15019175
J Comp Neurol. 1992 May 1;319(1):11-33
pubmed: 1375604

Auteurs

Yoshiko Kojima (Y)

Department of Otolaryngology- Head and Neck Surgery, Washington National Primate Research Center, University of Washington, Seattle, WA 98195-7330 ykojima@uw.edu.

Paul J May (PJ)

Department of Neurobiology and Anatomical Sciences, University of Mississippi Medical Center, Jackson, MS 39216-4505.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH